Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Appl Environ Microbiol ; 75(19): 6198-204, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19684171

ABSTRACT

Probiotics are live microorganisms which, when administered in adequate amounts, confer a health benefit on the host. Therefore, probiotic strains should be able to survive passage through the human gastrointestinal tract. Human gastrointestinal tract survival of probiotics in a low-fat spread matrix has, however, never been tested. The objective of this randomized, double-blind, placebo-controlled human intervention study was to test the human gastrointestinal tract survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG after daily consumption of a low-fat probiotic spread by using traditional culturing, as well as molecular methods. Forty-two healthy human volunteers were randomly assigned to one of three treatment groups provided with 20 g of placebo spread (n = 13), 20 g of spread with a target dose of 1 x 10(9) CFU of L. reuteri DSM 17938 (n = 13), or 20 g of spread with a target dose of 5 x 10(9) CFU of L. rhamnosus GG (n = 16) daily for 3 weeks. Fecal samples were obtained before and after the intervention period. A significant increase, compared to the baseline, in the recovery of viable probiotic lactobacilli in fecal samples was demonstrated after 3 weeks of daily consumption of the spread containing either L. reuteri DSM 17938 or L. rhamnosus GG by selective enumeration. In the placebo group, no increase was detected. The results of selective enumeration were supported by quantitative PCR, detecting a significant increase in DNA resulting from the probiotics after intervention. Overall, our results indicate for the first time that low-fat spread is a suitable carrier for these probiotic strains.


Subject(s)
Gastrointestinal Tract/microbiology , Lacticaseibacillus rhamnosus/physiology , Limosilactobacillus reuteri/physiology , Microbial Viability , Probiotics/administration & dosage , Probiotics/pharmacology , Administration, Oral , Adolescent , Adult , Colony Count, Microbial , Double-Blind Method , Feces/microbiology , Female , Human Experimentation , Humans , Male , Middle Aged , Placebos/administration & dosage , Young Adult
2.
Nutr Rev ; 65(11): 469-89, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18038940

ABSTRACT

Probiotics and prebiotics have long been appreciated for their positive influences on gut health. Research on the mechanisms and effects of these agents shows that their impact reaches beyond the intestine. Effects on the microecology and pathology of the oral cavity, stomach, and vaginal tract have been observed. Likely mediated through immune influences, systemic effects such as reduced severity of colds or other respiratory conditions, impact on allergy incidence and symptoms, and reduced absences from work or daycare have also been noted. These observations, among others, suggest a broader spectrum of influence than commonly considered for these unique substances.


Subject(s)
Digestive System/microbiology , Immune System/microbiology , Probiotics , Respiratory System/microbiology , Urogenital System/microbiology , Animals , Chickens , Dietary Supplements/microbiology , Digestive System/immunology , Female , Humans , Hypersensitivity , Immune System/immunology , Male , Randomized Controlled Trials as Topic , Rats , Respiratory System/immunology , Urogenital System/immunology
3.
Nutr J ; 5: 28, 2006 Nov 21.
Article in English | MEDLINE | ID: mdl-17118191

ABSTRACT

BACKGROUND: Supplementation of nutritional deficiencies helps to improve immune function and resistance to infections in malnourished subjects. However, the suggested benefits of dietary supplementation for immune function in healthy well nourished subjects is less clear. Among the food constituents frequently associated with beneficial effects on immune function are micronutrients such as vitamin C, vitamin E, beta-carotene and zinc, and colostrum. This study was designed to investigate the effects these ingredients on immune function markers in healthy volunteers. METHODS: In a double-blind, randomized, parallel, 2*2, placebo-controlled intervention study one hundred thirty-eight healthy volunteers aged 40-80 y (average 57 +/- 10 y) received one of the following treatments: (1) bovine colostrum concentrate 1.2 g/d (equivalent to approximately 500 mg/d immunoglobulins), (2) micronutrient mix of 288 mg vitamin E, 375 mg vitamin C, 12 mg beta-carotene and 15 mg zinc/day, (3) combination of colostrum and micronutrient mix, or (4) placebo. Several immune function parameters were assessed after 6 and 10 weeks. Data were analyzed by analysis of variance. Groups were combined to test micronutrient treatment versus no micronutrient treatment, and colostrum treatment versus no colostrum treatment. RESULTS: Overall, consumption of the micronutrient mix significantly enhanced delayed-type hypersensitivity (DTH) responses (p < 0.05). Adjusted covariance analysis showed a positive association between DTH and age. Separate analysis of younger and older age groups indicated that it was the older population that benefited from micronutrient consumption. The other immune function parameters including responses to systemic tetanus and oral typhoid vaccination, phagocytosis, oxidative burst, lymphocyte proliferation and lymphocyte subset distribution were neither affected by the consumption of micronutrients nor by the consumption of bovine colostrum concentrate. CONCLUSION: Consumption of bovine colostrum had no effect on any of the immune parameters assessed. The micronutrient mix enhanced cellular immunity as measured by DTH, with an increased effect by incremental age, but did not affect any of the other immune parameters measured. Although correlations between decreased DTH and enhanced risk of certain infection have been reported, it remains unclear whether and enhanced DTH response actually improves immune defense. The present data suggests that improvement of immune parameters in a population with a generally good immune and nutritional status is limited and that improvement of immune function in this population may be difficult.


Subject(s)
Colostrum , Dietary Supplements , Immunity/drug effects , Micronutrients/administration & dosage , Adult , Aged , Aged, 80 and over , Aging , Animals , Ascorbic Acid/blood , Cattle , Cell Proliferation/drug effects , Double-Blind Method , Female , Humans , Hypersensitivity, Delayed/immunology , Leukocyte Count , Lymphocytes/cytology , Male , Middle Aged , Phagocytosis/drug effects , Tetanus Toxoid/administration & dosage , Typhoid-Paratyphoid Vaccines/administration & dosage , Vaccination , Vitamin E/blood , beta Carotene/blood
4.
Int Immunol ; 15(6): 731-9, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12750357

ABSTRACT

The mucosal immune system is uniquely adapted to elicit immune responses against pathogens but also to induce tolerogenic responses to harmless antigens. In mice, nasal application of ovalbumin (OVA) leads to suppression of both T(h)1 and T(h)2 responses. This tolerance can be transferred to naive mice by CD4(+) T(r) cells from the spleen. Using the allotypic Ly5 system, we were able to demonstrate in vivo that T(r) cells not only suppress naive CD4(+) T cells, but also induce them to differentiate into T(r) cells. The effector function of these mucosal T(r) cells is not restricted by cytokine polarization, since T(r) cells from T(h)1-tolerant mice can suppress a T(h)2 response and vice versa. Transfer of splenic CD4(+)CD25(+) and CD4(+)CD25(-) T cell subsets from OVA-tolerized mice revealed that both subsets were equally able to suppress a delayed-type hypersensitivity response in acceptor mice. In contrast to the CD25(-) T cell subset, the CD25(+) cells were not specific for the antigen used for tolerization. Together, these findings demonstrate a role for CD4(+)CD25(-) T(r) cells in mucosal tolerance, which suppresses CD4(+) T cells in an antigen-specific fashion, irrespective of initial T(h)1/T(h)2 skewing of the immune response. This offers a major advantage in the manipulation of mucosal tolerance for the treatment of highly cytokine-polarized disorders such as asthma and autoimmune diseases.


Subject(s)
Adoptive Transfer , CD4-Positive T-Lymphocytes/immunology , Immune Tolerance/immunology , Lymphocyte Activation/immunology , Nasal Mucosa/immunology , Animals , Female , Mice , Ovalbumin/administration & dosage , Ovalbumin/immunology , Receptors, Interleukin-2/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...